Paris pharmaceutical giant Sanofi established a Connecticut presence in 2017 when it acquired a poster child of the state’s nascent bioscience industry, Protein Sciences Corp., in a deal valued at $750 million.
Now, Sanofi quietly plans to close Protein Sciences’ former headquarters at 1000 Research Parkway in Meriden and exit the state by the end of 2024.
A Sanofi spokesperson confirmed to the Hartford Business Journal that the company will move its Meriden…
Read More…